Weinstock R S, Goland R S, Shane E, Clemens T L, Lindsay R, Bilezikian J P
State University of New York, Syracuse.
J Bone Miner Res. 1989 Feb;4(1):97-101. doi: 10.1002/jbmr.5650040114.
Bone mineral density (BMD) was assessed in 28 women with type II diabetes mellitus and compared to 207 age-matched nondiabetic women. Mean BMD, as measured by dual-photon absorptiometry, 1.12 +/- 0.3 g/cm2 (+/- SEM), was similar to the mean BMD of control subjects, 1.06 +/- 0.1 g/cm2. Only 1 of the 28 diabetic patients had a BMD less than 0.95 g/cm2 ("fracture threshold"), whereas 25% of the control subjects had a BMD below that level. When diabetic and control subjects were matched for weight as well as age, the data continued to show similar BMD among both groups. Moreover, the disparity between the proportion of weight-matched controls (25%) and diabetic subjects (1 of 28) with a BMD below the fracture threshold persisted. Among the group of 17 diabetic subjects receiving insulin, there was a positive relationship between BMD and insulin dose. There was no significant relationship between BMD, duration of diabetes, or hemoglobin Alc. Thus, women with type II diabetes are not at increased risk for diminished BMD and may be protected against bone loss.
对28名II型糖尿病女性进行了骨矿物质密度(BMD)评估,并与207名年龄匹配的非糖尿病女性进行比较。通过双能X线吸收法测量,糖尿病女性的平均BMD为1.12±0.3g/cm²(±标准误),与对照组女性的平均BMD 1.06±0.1g/cm²相似。28名糖尿病患者中只有1人的BMD低于0.95g/cm²(“骨折阈值”),而对照组中有25%的人的BMD低于该水平。当糖尿病患者和对照组在体重和年龄上进行匹配时,数据继续显示两组的BMD相似。此外,体重匹配的对照组(25%)和BMD低于骨折阈值的糖尿病患者(28人中的1人)之间的差异仍然存在。在17名接受胰岛素治疗的糖尿病患者中,BMD与胰岛素剂量之间存在正相关关系。BMD、糖尿病病程或糖化血红蛋白之间无显著关系。因此,II型糖尿病女性发生BMD降低的风险并未增加,且可能对骨质流失具有保护作用。